(JDIX) today announced its public launch, introducing its AI-powered clinical platforms JDIQ™ and JDIM™, designed to support ...
ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...
Objectives To define a clinically meaningful treatment response definition for haemolytic anaemia, that will form part of a ...
The newly introduced AI-powered study build engine marks the first phase of ClinCapture's broader intelligent trial roadmap. By automating protocol translation, Captivate establishes a foundation for ...
Improving LDCT screening rates within a large multidisciplinary community based practice using integrated ACR accredited imaging centers. Using an AI trial screening tool to assess language as a ...
The pseudomonal infections clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline ...
Niraparib is an orally administered selective poly ADP-ribose polymerase (PARP) inhibitor. In April 2016, Janssen entered a worldwide (except Japan) collaboration and license agreement with TESARO for ...
DelveInsight's,“ Renal Cancer Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Renal Cancer pipeline landscape. It covers the Renal Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results